Development of Pandemic Vaccines: ERVEBO Case Study

Preventative vaccines are considered one of the most cost-effective and efficient means to contain outbreaks and prevent pandemics. However, the requirements to gain licensure and manufacture a vaccine for human use are complex, costly, and time-consuming. The 2013–2016 Ebola virus disease (EVD) out...

Descripción completa

Detalles Bibliográficos
Autores principales: Wolf, Jayanthi, Jannat, Risat, Dubey, Sheri, Troth, Sean, Onorato, Matthew T., Coller, Beth-Ann, Hanson, Mary E., Simon, Jakub K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7996233/
https://www.ncbi.nlm.nih.gov/pubmed/33668698
http://dx.doi.org/10.3390/vaccines9030190

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7996233/
https://www.ncbi.nlm.nih.gov/pubmed/33668698
http://dx.doi.org/10.3390/vaccines9030190

Ejemplares similares